Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,032 | 71,396 | 53,804 | 91,877 | 182,476 |
| Marketable Securities | 114,648 | 141,891 | 47,946 | 52,379 | 7,966 |
| Receivables | N/A | N/A | 120 | 17 | N/A |
| Other current assets | 674 | 15,626 | 16,385 | 16,544 | 14,667 |
| TOTAL | $181,293 | $231,406 | $121,287 | $163,765 | $211,886 |
| Non-Current Assets | |||||
| PPE Net | 20,572 | 22,046 | 23,828 | 24,956 | 24,404 |
| Other Non-Current Assets | 140,868 | 131,560 | 133,894 | 139,442 | 61,218 |
| TOTAL | $161,440 | $153,606 | $157,722 | $164,398 | $85,622 |
| Total Assets | $342,733 | $385,012 | $279,009 | $328,163 | $297,508 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,887 | 9,354 | 6,378 | 10,025 | 11,351 |
| Accrued Expenses | 12,600 | 11,000 | 12,158 | 9,191 | 15,904 |
| TOTAL | $37,448 | $35,019 | $34,109 | $34,288 | $37,961 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,824 | 6,951 | 8,315 | 8,214 | 7,092 |
| Other Non-Current Liabilities | 126,290 | 128,421 | 124,478 | 126,293 | 43,180 |
| TOTAL | $184,417 | $188,172 | $184,040 | $186,951 | $106,398 |
| Total Liabilities | $221,865 | $223,191 | $218,149 | $221,239 | $144,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 180,552 | 180,511 | 134,574 | 131,295 | 131,161 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -888,354 | -842,275 | -791,693 | -739,102 | -687,212 |
| Other shareholders' equity | 82 | 33 | -10 | -15 | 1 |
| TOTAL | $120,868 | $161,821 | $60,860 | $106,924 | $153,149 |
| Total Liabilities And Equity | $342,733 | $385,012 | $279,009 | $328,163 | $297,508 |